Recent Comments

Comment RSS

Dengue Fever News and Research RSS Feed - Dengue Fever News and Research

Dengue (DF) and dengue hemorrhagic fever (DHF) are caused by one of four closely related, but antigenically distinct, virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4), of the genus Flavivirus. Infection with one of these serotypes provides immunity to only that serotype for life, so persons living in a dengue-endemic area can have more than one dengue infection during their lifetime. DF and DHF are primarily diseases of tropical and sub tropical areas, and the four different dengue serotypes are maintained in a cycle that involves humans and the Aedes mosquito. However, Aedes aegypti, a domestic, day-biting mosquito that prefers to feed on humans, is the most common Aedes species. Infections produce a spectrum of clinical illness ranging from a nonspecific viral syndrome to severe and fatal hemorrhagic disease. Important risk factors for DHF include the strain of the infecting virus, as well as the age, and especially the prior dengue infection history of the patient.

Publication serves as a guide to build productive partnerships and overcome global health challenges

21. November 2009 00:21
Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health. [More]

Posted in: Disease/Infection News | Healthcare News

Tags: , , , , ,

First nationwide human immunology registry for infectious disease research

21. November 2009 00:00
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide human immunology registry for infectious disease research. The new registry was developed to help clinicians and researchers better understand the human immune response to emerging and re-emerging infectious diseases. [More]

Posted in: Device / Technology News | Disease/Infection News | Healthcare News

Tags: , , , ,

Researchers to discover new vaccine against infection from Lyme disease

20. November 2009 00:30
A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. [More]

Posted in: Disease/Infection News

Tags: , , , , , ,

IBM scientists work with Rizzoli Orthopedic Institute to use BioMIMS to treat genetic skeletal diseases

18. November 2009 07:59
IBM ( IBM) announced today that its Research scientists are working with the Rizzoli Orthopedic Institute, in Bologna, Italy, to use information technology to better address treatment and research for rare genetic skeletal diseases. [More]

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

18. November 2009 05:12
IBM (IBM) scientists have created a one-step point-of-care-diagnostic test, based on an innovative silicon chip, that requires less sample volume, is significantly faster, portable, easy to use, and can test for many diseases, including one of world's leading causes of death, cardiovascular disease. [More]

Rainfall and temperature linked with dengue fever

16. November 2009 04:05
Research published this week in PLoS Medicine demonstrates associations between local rainfall and temperature and cases of dengue fever, which affects an estimated fifty million people per year worldwide. [More]

Posted in: Disease/Infection News

Tags: ,

Drug companies collaborate with nonprofit organizations to fight "neglected" diseases in the developing world

12. November 2009 00:06
Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. Those hard-to-treat diseases include malaria, tuberculosis, dengue fever, and other conditions. That's the topic of the cover story scheduled for the current issue of Chemical & Engineering News, ACS' weekly newsmagazine. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , ,

Also in Global Health: Child sexual abuse in Zimbabwe; dengue outbreak in Cape Verde; program reduces waste in Kenya slums

11. November 2009 00:18
The Mail & Guardian examines how the "economic collapse" in Zimbabwe has contributed to rising numbers of children falling victims to sexual abuse. "A single clinic in the capital, Harare, says it has treated nearly 30,000 girls and boys who were abused in the past four years - an average of 20 per day." The article examines other contributing factors to the sexual abuse of children in Zimbabwe and a recent program that aims to make schools safe places for Zimbabwe's children (11/10). [More]

Posted in: Child Health News | Disease/Infection News

Tags: , ,

Human movement is a key factor for dengue spread in Brazil

10. November 2009 01:57
Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. The results, based on data from a severe epidemic in 2007-2008, contribute to new understanding on the dynamics of dengue fever in the second largest city in Brazil. Details are published November 10 in the open-access journal PLoS Neglected Tropical Diseases. [More]

Posted in: Disease/Infection News

Tags: , , ,

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

6. November 2009 23:52
Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , , , , ,

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

5. November 2009 00:46
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism. [More]

Rega Institute and CD3 to receive funds for new medication research for dengue treatment

26. October 2009 05:46
The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'. [More]

Posted in: Disease/Infection News

Tags: , , , ,

Wellcome Trust's 91M fund aims at developing new drugs related to the dengue fever virus

26. October 2009 01:54
The Wellcome Trust spends over 600 million pounds each year to support its mission to foster and promote research with the aim to improving human and animal health. This funding supports basic research as well as technology transfer, the transfer of academic knowledge and technology to the corporate environment. [More]

Posted in: Disease/Infection News

Tags: , , , , , , , , ,

Recent releases in Global Health

24. October 2009 02:01
"The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue," write the authors of a Lancet Infectious Diseases review that examines what is known about the virus and progress in the development of a dengue vaccine (Webster et. al, 11/09). [More]

106m infants worldwide received vaccines last year, coverage gaps remain, report says

22. October 2009 00:06
A joint report by the WHO, UNICEF and the World Bank on worldwide vaccination efforts released Wednesday found "a record 106 million infants were vaccinated last year against life-threatening diseases, but nearly a fifth of the world's babies still are not protected fully," the Associated Press reports. [More]

Posted in: Child Health News | Pharmaceutical News

Tags: , , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.